Boothbay Fund Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.31M | Sell |
|
|||||
|
2025
Q2 | $1.68M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $297K | Buy |
|
|||||
|
2023
Q2 | $253K | Hold |
|
|||||
|
2023
Q1 | $221K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $245K | Sell |
|
|||||
|
2021
Q2 | $404K | Sell |
|
|||||
|
2021
Q1 | $845K | Sell |
|
|||||
|
2020
Q4 | $2.16M | Sell |
|
|||||
|
2020
Q3 | $1.66M | Buy |
|
|||||
|
2020
Q2 | $1.51M | Buy |
|
|||||
|
2020
Q1 | $830K | Buy |
|
|||||
|
2019
Q4 | $779K | Buy |
|
|||||
|
2019
Q3 | $346K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $146K | Hold |
|
|||||
|
2017
Q2 | $159K | Hold |
|
|||||
|
2017
Q1 | $169K | Buy |
|
|||||
|
2016
Q4 | $116 | Buy |
|